Medistim ASA (FRA:MD1)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of EUR 355.52 million. The enterprise value is 349.18 million.

Market Cap	355.52M
Enterprise Value	349.18M

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date	Oct 24, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	18.27M
Shares Outstanding	n/a
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	-0.33%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.61M

Valuation Ratios

The trailing PE ratio is 32.21 and the forward PE ratio is 28.39.

PE Ratio	32.21
Forward PE	28.39
PS Ratio	6.72
PB Ratio	11.00
P/TBV Ratio	13.32
P/FCF Ratio	28.91
P/OCF Ratio	27.75
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.14, with an EV/FCF ratio of 28.39.

EV / Earnings	31.63
EV / Sales	6.51
EV / EBITDA	21.14
EV / EBIT	23.92
EV / FCF	28.39

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.06.

Current Ratio	3.14
Quick Ratio	1.73
Debt / Equity	0.06
Debt / EBITDA	0.11
Debt / FCF	0.15
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 34.19% and return on invested capital (ROIC) is 26.75%.

Return on Equity (ROE)	34.19%
Return on Assets (ROA)	21.13%
Return on Invested Capital (ROIC)	26.75%
Return on Capital Employed (ROCE)	41.59%
Revenue Per Employee	343,289
Profits Per Employee	71,677
Employee Count	154
Asset Turnover	1.24
Inventory Turnover	0.71

Taxes

In the past 12 months, Medistim ASA has paid 3.44 million in taxes.

Income Tax	3.44M
Effective Tax Rate	23.75%

Stock Price Statistics

The stock price has increased by +31.76% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.76%
50-Day Moving Average	20.06
200-Day Moving Average	16.32
Relative Strength Index (RSI)	42.53
Average Volume (20 Days)	2

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of EUR 52.87 million and earned 11.04 million in profits. Earnings per share was 0.60.

Revenue	52.87M
Gross Profit	42.69M
Operating Income	14.40M
Pretax Income	14.48M
Net Income	11.04M
EBITDA	15.55M
EBIT	14.40M
Earnings Per Share (EPS)	0.60

Balance Sheet

The company has 8.11 million in cash and 1.85 million in debt, giving a net cash position of 6.26 million.

Cash & Cash Equivalents	8.11M
Total Debt	1.85M
Net Cash	6.26M
Net Cash Per Share	n/a
Equity (Book Value)	32.31M
Book Value Per Share	1.77
Working Capital	22.25M

Cash Flow

In the last 12 months, operating cash flow was 12.81 million and capital expenditures -510,751, giving a free cash flow of 12.30 million.

Operating Cash Flow	12.81M
Capital Expenditures	-510,751
Free Cash Flow	12.30M
FCF Per Share	n/a

Margins

Gross margin is 80.74%, with operating and profit margins of 27.23% and 20.88%.

Gross Margin	80.74%
Operating Margin	27.23%
Pretax Margin	27.38%
Profit Margin	20.88%
EBITDA Margin	29.42%
EBIT Margin	27.23%
FCF Margin	23.26%

Dividends & Yields

This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 2.60%.

Dividend Per Share	0.51
Dividend Yield	2.60%
Dividend Growth (YoY)	33.88%
Years of Dividend Growth	n/a
Payout Ratio	83.79%
Buyback Yield	0.07%
Shareholder Yield	2.68%
Earnings Yield	3.10%
FCF Yield	3.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6